Exane Derivatives’s Bilibili BILI Stock Holding History

Exane Derivatives’s Portfolio BILI Stock Details BILI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-140	Closed	-$3.58K	–	808
2022 Q1	$3.58K	Hold	140	–	–	﹤0.01%	716
2021 Q4	$6.5K	Sell	140 -57	-29%	-$3.81K	﹤0.01%	608
2021 Q3	$13K	Sell	197 -269	-58%	-$23K	﹤0.01%	701
2021 Q2	$51.4K	Buy	+466	New	+$50.5K	0.01%	647
2021 Q1	–	Sell	-19	Closed	-$1.63K	–	925
2020 Q4	$1.63K	Sell	19 -6,200	-100%	-$363K	﹤0.01%	643
2020 Q3	$259K	Hold	6,219	–	–	0.07%	189
2020 Q2	$288K	Buy	+6,219	New	+$202K	0.08%	192

Other funds holding BILI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Alibaba Group Causeway Bay, Hong Kong $509M AUM 25.62% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exane Derivatives's BILI Position: Q2 2022 in Review

Exane Derivatives sold out of Bilibili (BILI) in Q2 2022, closing a stake of 140 shares — an estimated $3.58K sold.

Exane Derivatives first reported a position in BILI in Q2 2020 and held it in 7 quarters. The position peaked at $288K in Q2 2020. 191 funds tracked by Wall St. Rank hold BILI as of Q2 2022.

Exane Derivatives reported no remaining Bilibili position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 140 Bilibili shares in Q2 2022, an estimated $3.58K.
Exane Derivatives first reported a position in Bilibili in Q2 2020 and held it in 7 quarters.
Exane Derivatives's Bilibili position peaked at $288K in Q2 2020.
191 funds tracked by Wall St. Rank held Bilibili as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.